APA (7th ed.) Citation

Kim, S., Kim, K. H., Jung, H., Jeong, E., Lee, H., Kwon, J., . . . Kim, S. (2025). Elevated Serum IL-6 as a Negative Prognostic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Validation. Journal of Cancer, 16(3), 802. https://doi.org/10.7150/jca.104759

Chicago Style (17th ed.) Citation

Kim, Sup, et al. "Elevated Serum IL-6 as a Negative Prognostic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Validation." Journal of Cancer 16, no. 3 (2025): 802. https://doi.org/10.7150/jca.104759.

MLA (9th ed.) Citation

Kim, Sup, et al. "Elevated Serum IL-6 as a Negative Prognostic Biomarker in Glioblastoma: Integrating Bioinformatics and Clinical Validation." Journal of Cancer, vol. 16, no. 3, 2025, p. 802, https://doi.org/10.7150/jca.104759.